Cross Research S.A.: Clinical Trials

30 trials sponsored by Cross Research S.A., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

27 completed, 1 recruiting, 1 terminated, 1 unknown. 22 Phase 1, 4 Phase 2, 2 Not applicable, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 122Completed 22
Phase 24Completed 4
Not applicable2Recruiting 1, Unknown 1
Phase 32Completed 1, Terminated 1

Follow Cross Research S.A.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Palatability Study of Five Formulations of Benzydamine HCl Lozenges
benzydamine HCl - Healthy Volunteers, Palatability
Phase 1CompletedAziende Chimiche Riunite Angelini Francesco S.p.A1202025-04-132025-09-30
The Effectiveness of Heat Treatment on Knee Pain in Patients With Osteoarthritis - an International, Multicenter Clinical Investigation
Knee Heatwraps - Pain Management, Osteoarthritis
Not applicableRecruitingAziende Chimiche Riunite Angelini Francesco S.p.A802024-10-212025-09-08
Efficacy and Safety of Chloroprocaine 3% Gel and Oxybuprocaine 0.4% Eye Drops Anesthesia in Pediatric Population
Chloroprocaine 3% eye gel, Oxybuprocaine Hydrochloride 4 Mg/mL Eye Drops - Local Anesthetic
Phase 3CompletedSintetica SA742024-05-232026-03-09
Clinical Performance and Safety of Suture-TOOL
Suture-TOOL - Laparotomy, Incisional Hernia
Not applicableUnknownSuturion AB382023-01-102023-01-23
Study to Evaluate the Safety and Concentrations of Monoclonal Antibody Against Virus That Causes COVID-19 Disease.
MAD0004J08, Placebo - COVID-19 Virus Disease
Phase 1CompletedToscana Life Sciences Sviluppo s.r.l.302021-03-012022-04-27
Riluzole Orodispersible Film Replicate Bioavailability
Riluzole 50 mg orodispersible film, Rilutek® 50 mg riluzole tablets - Healthy Participants
Phase 1CompletedCross Research S.A.542021-01-152025-05-02
Bioavailability Study of 300 mg Trazodone Hydrochloride (New Polymer) vs. 300 mg Trazodone Hydrochloride (Contramid® Prolonged-release Tablets) Under Fasting Conditions
Trazodone HCl - new polymer, Trazodone HCl - Contramid® - Healthy
Phase 1CompletedAziende Chimiche Riunite Angelini Francesco S.p.A282020-02-172021-11-29
Effects of RP101 in Post-menopausal Women With Dry Eye Syndrome
RP101 - Dry Eye Syndromes
Phase 2CompletedRedwood Pharma AB1042019-01-182019-12-20
Intrathecal Paracetamol Before Spinal Anaesthesia With Chloroprocaine HCl 1% for Short Knee Procedures
30 mg Paracetamol 3% (1 mL), 60 mg Paracetamol 3% (2 mL), 90 mg Paracetamol 3% (3 mL) - Pain, Postoperative
Phase 2CompletedSintetica SA602018-08-062021-06-24
Bioequivalence of Ketoprofen Oral Gel vs Ketoprofen Lysine Salt as Granules for Oral Solution
Ketoprofen Lysine, Ketoprofen Oral Product - Healthy
Phase 1CompletedAziende Chimiche Riunite Angelini Francesco S.p.A362018-07-232020-12-21
Bioequivalence of Flurbiprofen Lozenge vs Strepfen
Flurbiprofen Test 8.75 MG, Flurbiprofen Reference 8.75 MG - Healthy
Phase 1CompletedAziende Chimiche Riunite Angelini Francesco S.p.A242018-06-192020-12-17
A Novel Mouthwash Formulation CTP/BNZ With Mucus Adhesive Polymer
Cetylpyridinium Chloride 0.05% + Benzydamine HCl 0.15% + mucus adhesive polymer, Cetylpyridinium Chloride 0.05% + Benzydamine HCl 0.15% - Healthy
Phase 1CompletedAziende Chimiche Riunite Angelini Francesco S.p.A262017-11-142020-08-05
Safinamide Steady State Interaction With Rosuvastatin
100 mg safinamide, 20 mg rosuvastatin calcium period 1, 20 mg rosuvastatin calcium period 2 - Healthy
Phase 1CompletedCross Research S.A.242017-05-222017-08-01
Effects of Three Single Oral Doses of Trazodone on the QTc Interval Duration in Healthy Volunteers
Trazodone 20 mg, Trazodone 60 mg, Trazodone 140 mg - Healthy
Phase 1CompletedAziende Chimiche Riunite Angelini Francesco S.p.A202017-03-202020-07-31
Chloroprocaine 3% - Epidural Anesthesia in Unplanned Caesarean Section
Chloroprocaine, Ropivacaine - Unplanned Caesarean Section
Phase 3TerminatedSintetica SA162016-10-012023-11-21
Crossover, Single Dose, Two-stage Bioequivalence Study of SCMC-Lys Salt 1.35 g Powder vs SCMC-Lys Salt 90 mg/mL Syrup
SCMC-lys powder 1.35 g, Fluifort® syrup - Bronchitis
Phase 1CompletedDompé Farmaceutici S.p.A302016-07-042024-11-18
Bioequivalence Study of Ibuprofen 200 mg/5 mL Oral Suspension vs. MOMENT 200 mg Coated Tablet
Ibuprofen 200 mg/5 mL oral suspension, MOMENT 200 mg coated tablet - Healthy
Phase 1CompletedAziende Chimiche Riunite Angelini Francesco S.p.A602016-06-012016-09-15
Bioequivalence Study of Ibuprofen 400 mg/10 mL Oral Suspension vs. MOMENTACT 400 mg Film-coated Tablet
Ibuprofen 400 mg/10 mL oral suspension, MOMENT 400 mg coated tablet - Healthy
Phase 1CompletedAziende Chimiche Riunite Angelini Francesco S.p.A602016-05-012016-09-15
Bioequivalence Study of One Tablet of Paracetamol 1000 mg + Codeine 30 mg vs. Two Tablets of Paracetamol 500 mg + Codeine 30 mg
Paracetamol 1000 mg/codeine phosphate hemihydrate 30 mg tablet, Paracetamol 500 mg/codeine phosphate hemihydrate 30 mg tablet - Healthy
Phase 1CompletedAziende Chimiche Riunite Angelini Francesco S.p.A462016-04-012016-09-16
Tolerability and Pharmacokinetic Study of Econazole Nitrate Plus Benzydamine HCl Vaginal Pessary
Econazole nitrate 150 mg plus Benzydamine HCl 6 mg vaginal pessary, Placebo plus Econazole nitrate 150 mg vaginal pessary, Placebo plus Benzydamine HCl 6 mg vaginal pessary - Healthy Women
Phase 1CompletedAziende Chimiche Riunite Angelini Francesco S.p.A492016-03-042017-02-07

Showing 20 of 30. Sign in to see all of them.

Conditions studied

Dry Eye Syndromes (2)  ·  Neuralgia (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Agnosia (1)  ·  Anthrax (1)  ·  Bronchitis (1)  ·  COVID-19 (1)  ·  Dysmenorrhea (1)  ·  Headache (1)  ·  Incisional Hernia (1)  ·  Keratoconjunctivitis Sicca (1)  ·  Leukemia, Hairy Cell (1)  ·  Osteoarthritis (1)  ·  Pain (1)  ·  Pain, Postoperative (1)

Interventions

Benzydamine (4)  ·  Ibuprofen (3)  ·  Acetaminophen (2)  ·  Econazole (2)  ·  Solutions (2)  ·  Suspensions (2)  ·  Trazodone (2)  ·  chloroprocaine (2)  ·  safinamide (2)  ·  Cetylpyridinium (1)  ·  Diclofenac (1)  ·  Filgrastim (1)  ·  Injections (1)  ·  MAD0004J08 (1)  ·  Metered Dose Inhalers (1)

Countries

Switzerland (22)  ·  Austria (2)  ·  Italy (2)  ·  Belgium (1)  ·  Germany (1)  ·  Hungary (1)  ·  South Africa (1)  ·  Sweden (1)

Top investigators

Milko Radicioni, MD (14)  ·  Andrea Paolini (1)  ·  Antonio Rusca, MD (1)  ·  Antonio Rusca, MD, FMH (1)  ·  Claudio Camponovo, MD (1)  ·  Daniel R Malan, MD (1)  ·  Marc Van de Velde, MD (1)  ·  Marcus Edelhamre, MD Phd (1)  ·  Milko M Radicioni, MD PhD (1)  ·  Milko Radicioni (1)  ·  Ruggero G Fariello, MD FAAN (1)

Results publications

PMID 21615456, PMID 24555723, PMID 30944103, PMID 31549201, PMID 32410819, PMID 32488885, PMID 33710587, PMID 34473343, PMID 35477725, PMID 39845163